Searching map area
Y
Y
N
N
Y
Y
N
N
Home
Map
Random
Lists
Rate Things
Swipe
Explore
Everything
Film
TV
Music
Books
Games
People
Characters
Places
Food
Life
Ideas
Organizations
Schools
Posts
News
Memes
Flags
Papers
Art
Space
Chemistry
Technology
Events
Emoji
Instruments
Other
Join YYNN
Sign in
Carol Aghajanian
?
TBD
Gynecologic oncologist, researcher
Join to rate
Ratings
About
Ratings
0
Nobody has rated this yet. Be the first!
Works
15
Squamous cell carcinoma arising in mature cystic teratoma of the ovary: a case series and review of the literature
scientific article published on 22 January 2007
PO004LBA/#1515 Efficacy and safety of avutometinib + defactinib in recurrent low-grade serous ovarian cancer following prior systemic therapy
#523 Initial efficacy and safety results from ENGOT-Ov60/GOG-3052/RAMP 201: a phase 2 study of avutometinib (VS-6766) ± defactinib in recurrent low-grade serous ovarian cancer (LGSOC)
Supplementary Data 1 from Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer
Intraperitoneal cisplatin with intraperitoneal gemcitabine in patients with epithelial ovarian cancer: results of a phase I/II Trial
scientific article
Predicting outcomes in female germ cell patients using a modified International Germ Cell Cancer Collaborative Group classification system to guide management (100)
scientific article published in August 2022
Data from Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer
Data from Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib vs Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer
Supplementary Data 1 from Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib vs Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer
Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm
scientific article published on 23 April 2009
5 more
Lists
0
Join to rate
Instance of
Human
Occupation
Researcher
Gynaecologist
oncologist
Wikidata